Tobias Mueller

3.6k total citations
33 papers, 1.3k citations indexed

About

Tobias Mueller is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Tobias Mueller has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Tobias Mueller's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Liver Disease and Transplantation (5 papers). Tobias Mueller is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Liver Disease and Transplantation (5 papers). Tobias Mueller collaborates with scholars based in Germany, United States and Israel. Tobias Mueller's co-authors include Oren Shibolet, Thomas Berg, Daniel K. Podolsky, Ramnik J. Xavier, Boaz Tirosh, Marcus Dittrich, Ian M. Rosenberg, Eckart Schott, Hermann Einsele and Jean‐Pierre Desager and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Tobias Mueller

33 papers receiving 1.3k citations

Peers

Tobias Mueller
Cong Xu China
Ki Jeong Lee United States
Jun Inoue Japan
Vicky M.-H. Sung United States
Cong Xu China
Tobias Mueller
Citations per year, relative to Tobias Mueller Tobias Mueller (= 1×) peers Cong Xu

Countries citing papers authored by Tobias Mueller

Since Specialization
Citations

This map shows the geographic impact of Tobias Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Mueller more than expected).

Fields of papers citing papers by Tobias Mueller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Mueller. The network helps show where Tobias Mueller may publish in the future.

Co-authorship network of co-authors of Tobias Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Mueller. A scholar is included among the top collaborators of Tobias Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Mueller. Tobias Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delbridge, Claire, Kirsten Jung, Tobias Mueller, et al.. (2024). Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biology. Neuro-Oncology Advances. 6(1). vdae106–vdae106. 3 indexed citations
2.
Zhu, Pinkuan, Tobias Mueller, Frederik Sommer, et al.. (2024). Genome Comparisons between Botrytis fabae and the Closely Related Gray Mold Fungus Botrytis cinerea Reveal Possible Explanations for Their Contrasting Host Ranges. Journal of Fungi. 10(3). 216–216. 3 indexed citations
3.
Özdirik, Burcin, et al.. (2022). Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis. Journal of Clinical Medicine. 11(9). 2479–2479. 2 indexed citations
4.
Bock, C.–Thomas, Jörg Hofmann, Mira Choi, et al.. (2020). Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E. International Journal of Environmental Research and Public Health. 17(1). 341–341. 7 indexed citations
5.
Posa, Andreas, et al.. (2020). Basilar artery thrombosis during sexual intercourse. Journal of Clinical Neuroscience. 74. 238–240. 1 indexed citations
6.
Wuensch, Tilo, Tobias Mueller, Tobias Jung, et al.. (2017). Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients. European Journal of Gastroenterology & Hepatology. 29(4). 456–463. 12 indexed citations
7.
Morton, Oliver, Marcus Dittrich, Tobias Mueller, et al.. (2014). Gene Expression Profiles of Human Dendritic Cells Interacting with Aspergillus fumigatus in a Bilayer Model of the Alveolar Epithelium/Endothelium Interface. PLoS ONE. 9(5). e98279–e98279. 19 indexed citations
8.
Duell, Johannes, Marcus Dittrich, Tanja Bedke, et al.. (2014). Crucial Role of Regulatory T Cells in Predicting the Outcome of the T Cell Engaging Antibody Blinatumomab in Relapsed and Refractory B Precursor ALL Patients. Blood. 124(21). 2291–2291. 10 indexed citations
9.
Chung, Raymond T., et al.. (2013). CCAAT/Enhancer-Binding Protein Homologous (CHOP) Protein Promotes Carcinogenesis in the DEN-Induced Hepatocellular Carcinoma Model. PLoS ONE. 8(12). e81065–e81065. 34 indexed citations
10.
Mueller, Tobias, Águeda González‐Rodríguez, Ángela M. Valverde, et al.. (2013). CHOP is a critical regulator of acetaminophen-induced hepatotoxicity. Journal of Hepatology. 59(3). 495–503. 152 indexed citations
11.
Marques, Andreas Mas, Tobias Mueller, Justus Welke, et al.. (2009). Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection. Infection Genetics and Evolution. 9(5). 847–852. 11 indexed citations
12.
Halangk, Juliane, Christoph Sarrazin, Konrad Neumann, et al.. (2008). Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection. Journal of Hepatology. 49(3). 339–345. 8 indexed citations
13.
Wasmuth, Hermann E., Carmen G. Tag, Claus Hellerbrand, et al.. (2008). The Marburg I variant (G534E) of the factor VII–activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet‐derived growth factor BB†. Hepatology. 49(3). 775–780. 38 indexed citations
14.
Shibolet, Oren, Cosmas Giallourakis, Ian M. Rosenberg, et al.. (2007). AKAP13, a RhoA GTPase-specific Guanine Exchange Factor, Is a Novel Regulator of TLR2 Signaling. Journal of Biological Chemistry. 282(48). 35308–35317. 44 indexed citations
15.
Mueller, Tobias, Tomohiro Terada, Ian M. Rosenberg, Oren Shibolet, & Daniel K. Podolsky. (2006). Th2 Cytokines Down-Regulate TLR Expression and Function in Human Intestinal Epithelial Cells. The Journal of Immunology. 176(10). 5805–5814. 84 indexed citations
16.
Horsmans, Yves, Thomas Berg, Jean‐Pierre Desager, et al.. (2005). Isatoribine, an Agonist of TLR7, Reduces Plasma Virus Concentration in Chronic Hepatitis C Infection *. Hepatology. 42(3). 724–731. 195 indexed citations
17.
Sarrazin, Christoph, Thomas Berg, V Weich, et al.. (2005). GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection. Journal of Hepatology. 43(3). 388–393. 23 indexed citations
18.
Mueller, Tobias, Andreas Mas Marques, Christoph Sarrazin, et al.. (2004). Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection. Journal of Hepatology. 41(4). 652–658. 48 indexed citations
19.
Wasmuth, Hermann E., Tobias Mueller, Thomas Berg, et al.. (2004). CC chemokine receptor 5 ?32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia. Journal of Molecular Medicine. 82(1). 64–69. 27 indexed citations
20.
Wasmuth, Hermann E., Tobias Mueller, Thomas Berg, et al.. (2004). Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C†. Hepatology. 40(2). 327–334. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026